.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Daiichi Sankyo
Mallinckrodt
Healthtrust
Citi
Boehringer Ingelheim
Moodys
Chubb
Deloitte
Colorcon

Generated: July 25, 2017

DrugPatentWatch Database Preview

RAXAR Drug Profile

« Back to Dashboard

What is the patent landscape for Raxar, and what generic Raxar alternatives are available?

Raxar is a drug marketed by Otsuka and is included in one NDA.

The generic ingredient in RAXAR is grepafloxacin hydrochloride. Additional details are available on the grepafloxacin hydrochloride profile page.

Summary for Tradename: RAXAR

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list16
Patent Applications: see list122
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RAXAR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Otsuka
RAXAR
grepafloxacin hydrochloride
TABLET;ORAL020695-001Nov 6, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Otsuka
RAXAR
grepafloxacin hydrochloride
TABLET;ORAL020695-002May 14, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Otsuka
RAXAR
grepafloxacin hydrochloride
TABLET;ORAL020695-003May 14, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: RAXAR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Otsuka
RAXAR
grepafloxacin hydrochloride
TABLET;ORAL020695-001Nov 6, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Queensland Health
Medtronic
Julphar
UBS
Cipla
Harvard Business School
Baxter
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot